Victor F. Tapson
#152,470
Most Influential Person Across History
Victor F. Tapson's AcademicInfluence.com Rankings
Victor F. Tapsonengineering Degrees
Engineering
#4407
Historical Rank
Biomedical Engineering
#157
Historical Rank
Download Badge
Engineering Philosophy
Victor F. Tapson's Degrees
- PhD Biomedical Engineering Stanford University
Why Is Victor F. Tapson Influential?
(Suggest an Edit or Addition)Victor F. Tapson's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Remdesivir for the Treatment of Covid-19 — Final Report (2020) (4464)
- A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. (1996) (2445)
- Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study (2008) (1372)
- Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study (2001) (1225)
- Multidetector computed tomography for acute pulmonary embolism. (2006) (1195)
- Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19 (2020) (1138)
- Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease (2000) (1084)
- Sitaxsentan therapy for pulmonary arterial hypertension. (2004) (739)
- Selexipag for the Treatment of Pulmonary Arterial Hypertension. (2014) (641)
- Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension. (2006) (613)
- Beraprost therapy for pulmonary arterial hypertension. (2003) (608)
- ACCF/AHA Expert Conseusus Document (2009) (530)
- Updated evidence-based treatment algorithm in pulmonary arterial hypertension. (2009) (512)
- Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. (2007) (509)
- Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial. (2010) (488)
- A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. (2004) (486)
- Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension: Results of the Randomized IMPRES Study (2013) (481)
- Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. (2005) (409)
- Predictive and associative models to identify hospitalized medical patients at risk for VTE. (2011) (398)
- Acute pulmonary embolism. (2008) (395)
- International guidelines for the selection of lung transplant candidates. The American Society for Transplant Physicians (ASTP)/American Thoracic Society(ATS)/European Respiratory Society(ERS)/International Society for Heart and Lung Transplantation(ISHLT). (1998) (392)
- Syphilis (1887) (390)
- Clinical characteristics of patients with acute pulmonary embolism: data from PIOPED II. (2007) (387)
- Systematic review of the use of retrievable inferior vena cava filters. (2011) (386)
- Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II investigators. (2006) (367)
- Rivaroxaban for thromboprophylaxis in acutely ill medical patients. (2013) (354)
- Extended-Duration Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients With Recently Reduced Mobility (2010) (354)
- Gadolinium-Enhanced Magnetic Resonance Angiography for Pulmonary Embolism (2010) (352)
- The Evaluation of Suspected Pulmonary Embolism (2003) (336)
- The diagnostic approach to acute venous thromboembolism. Clinical practice guideline. American Thoracic Society. (1999) (336)
- Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators. (2011) (335)
- Upper-Extremity Deep Vein Thrombosis: A Prospective Registry of 592 Patients (2004) (324)
- Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial. (2012) (321)
- Effects of Long-term Infusion of Prostacyclin (Epoprostenol) on Echocardiographic Measures of Right Ventricular Structure and Function in Primary Pulmonary Hypertension (1997) (313)
- Chronic thromboembolic pulmonary hypertension (2004) (312)
- Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up study. (2003) (300)
- Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: a prospective, multicenter, open-label, 12-week trial. (2006) (287)
- Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients (2005) (254)
- Thrombosis during pregnancy and the postpartum period. (2005) (246)
- End points and clinical trial design in pulmonary arterial hypertension. (2004) (246)
- A Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism: The OPTALYSE PE Trial. (2018) (235)
- Physical and biological predictors of changes in whole-lung function following thoracic irradiation. (1997) (231)
- Efficacy and Safety of Treprostinil: An Epoprostenol Analog for Primary Pulmonary Hypertension (2003) (229)
- Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease. (1998) (212)
- Acute pulmonary embolism. (2004) (211)
- Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension. (2005) (205)
- A Prospective, Single-Arm, Multicenter Trial of Catheter-Directed Mechanical Thrombectomy for Intermediate-Risk Acute Pulmonary Embolism: The FLARE Study. (2019) (203)
- Oral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C2 study): a randomized controlled trial. (2013) (200)
- [Treatment goals of pulmonary hypertension]. (2014) (195)
- Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension (2015) (192)
- End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectives. (2004) (188)
- Antithrombotic therapy for venous thromboembolic disease. (1998) (180)
- Derivation and validation of multimarker prognostication for normotensive patients with acute symptomatic pulmonary embolism. (2014) (173)
- Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II Investigators. (2007) (172)
- Fungal Infections in Lung and Heart‐Lung Transplant Recipients: Report of 9 Cases and Review of the Literature (1996) (168)
- Antithrombotic therapy practices in US hospitals in an era of practice guidelines. (2005) (167)
- An official American Thoracic Society/Society of Thoracic Radiology clinical practice guideline: evaluation of suspected pulmonary embolism in pregnancy. (2011) (165)
- Incidence and prevalence of chronic thromboembolic pulmonary hypertension: from acute to chronic pulmonary embolism. (2006) (160)
- Gastroesophageal reflux as a reversible cause of allograft dysfunction after lung transplantation. (2000) (160)
- Massive pulmonary embolism during pregnancy successfully treated with recombinant tissue plasminogen activator: a case report and review of treatment options. (2002) (150)
- SAFETY OF AEROSOLIZED AMPHOTERICIN B LIPID COMPLEX IN LUNG TRANSPLANT RECIPIENTS12 (2001) (148)
- Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease. (2021) (143)
- The utility of SPECT lung perfusion scans in minimizing and assessing the physiologic consequences of thoracic irradiation. (1993) (141)
- Electrocardiography to define clinical status in primary pulmonary hypertension and pulmonary arterial hypertension secondary to collagen vascular disease. (2002) (138)
- Diagnosis, Treatment and Follow Up of Acute Pulmonary Embolism: Consensus Practice from the PERT Consortium (2019) (137)
- Infectious complications of lung transplantation (2001) (129)
- Community respiratory viral infection in adult lung transplant recipients. (1998) (128)
- A nitric oxide processing defect of red blood cells created by hypoxia: deficiency of S-nitrosohemoglobin in pulmonary hypertension. (2005) (126)
- Contemporary trends in the diagnosis and management of pulmonary arterial hypertension: an initiative to close the care gap. (2013) (124)
- Opinions regarding the diagnosis and management of venous thromboembolic disease. ACCP Consensus Committee on Pulmonary Embolism. American College of Chest Physicians. (1998) (122)
- American Thoracic Society documents: an official American Thoracic Society/Society of Thoracic Radiology Clinical Practice Guideline--Evaluation of Suspected Pulmonary Embolism in Pregnancy. (2012) (121)
- Isolation of Mycobacteria in Patients with Pulmonary Alveolar Proteinosis (1994) (115)
- Clinical practice. The evaluation of suspected pulmonary embolism. (2003) (113)
- Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs. (2005) (113)
- Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary hypertension: a placebo-controlled study. (2001) (111)
- Infections in patients with cystic fibrosis following lung transplantation. (1997) (109)
- Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus. (2000) (109)
- Rabbit antithymocyte globulin decreases acute rejection after lung transplantation: results of a randomized, prospective study. (1999) (106)
- Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol (2011) (104)
- Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group. (1997) (103)
- Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients (2010) (103)
- Long-term safety and efficacy of imatinib in pulmonary arterial hypertension. (2012) (101)
- Pharmacologic hemodynamic support in massive pulmonary embolism. (1997) (99)
- Influence of panel-reactive antibodies on posttransplant outcomes in lung transplant recipients. (2000) (99)
- D‐dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial (2014) (98)
- Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy. (2008) (98)
- Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension. (2011) (96)
- Bloodstream infections among patients treated with intravenous epoprostenol or intravenous treprostinil for pulmonary arterial hypertension--seven sites, United States, 2003-2006. (2007) (95)
- RESULTS OF A RANDOMIZED, PROSPECTIVE, MULTICENTER TRIAL OF MYCOPHENOLATE MOFETIL VERSUS AZATHIOPRINE IN THE PREVENTION OF ACUTE LUNG ALLOGRAFT REJECTION1 (2001) (95)
- Bronchial anastomotic complications in lung transplant recipients: virtual bronchoscopy for noninvasive assessment. (1998) (95)
- The role of smoking in coagulation and thromboembolism in chronic obstructive pulmonary disease. (2005) (95)
- Prospective comparison of helical CT and MR imaging in clinically suspected acute pulmonary embolism (1996) (93)
- Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension (2017) (92)
- Treatment goals of pulmonary hypertension. (2013) (92)
- Selective endothelinA receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease (2007) (89)
- Temporal trends and drug exposures in pulmonary hypertension: an American experience. (2006) (89)
- Significance of blood stream infection after lung transplantation: analysis in 176 consecutive patients. (2000) (87)
- Transcriptional Regulation of Bim by FOXO3a and Akt Mediates Scleroderma Serum–Induced Apoptosis in Endothelial Progenitor Cells (2008) (87)
- SPECT in Acute Pulmonary Embolism* (2009) (86)
- Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin-1 clearance and release in primary pulmonary hypertension. (1999) (86)
- Pulmonary angiography with MR imaging: preliminary clinical experience. (1993) (85)
- Risk factors associated with symptomatic pulmonary embolism in a large cohort of deep vein thrombosis patients (2005) (84)
- Detection of deep venous thrombosis: Prospective comparison of MR imaging and sonography (1996) (83)
- Antithrombotic and thrombolytic therapy: from evidence to application: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. (2004) (82)
- Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: Methodology for the EXCLAIM study (2006) (81)
- Longterm Survival Among Patients with Scleroderma-associated Pulmonary Arterial Hypertension Treated with Intravenous Epoprostenol (2009) (79)
- Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality. (2018) (77)
- Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial (2021) (75)
- Respiratory viral infections in lung transplant recipients: radiologic findings with clinical correlation. (1999) (74)
- Comprehensive assessment of right ventricular function in patients with pulmonary hypertension with global longitudinal peak systolic strain derived from multiple right ventricular views. (2014) (74)
- Anastomotic infections in lung transplant recipients. (2000) (73)
- Hyperpolarized 3He-enhanced MR imaging of lung transplant recipients: preliminary results. (1999) (72)
- Outcome of lung transplantation in patients with mycetomas. (2002) (70)
- Indigo Aspiration System for Treatment of Pulmonary Embolism: Results of the EXTRACT-PE Trial. (2021) (70)
- Inhaled nitric oxide selectively dilates pulmonary vasculature in adult patients with pulmonary hypertension, irrespective of etiology. (2000) (69)
- Effects of a telephone-based psychosocial intervention for patients awaiting lung transplantation. (2002) (67)
- Pulmonary cholesterol granulomas in patients with pulmonary artery hypertension: chest radiographic and CT findings. (1999) (65)
- Diagnostic yield of bronchoscopies after isolated lung transplantation. (1996) (65)
- The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH (2011) (65)
- Massive pulmonary embolism. Diagnostic and therapeutic strategies. (1995) (63)
- Targeting the Prostacyclin Pathway with Selexipag in Patients with Pulmonary Arterial Hypertension Receiving Double Combination Therapy: Insights from the Randomized Controlled GRIPHON Study (2018) (63)
- Thrombolytic therapy for acute pulmonary embolism: a critical appraisal. (2009) (63)
- Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report. (2017) (60)
- Candidal anastomotic infection in lung transplant recipients: successful treatment with a combination of systemic and inhaled antifungal agents. (1998) (59)
- Prognostic significance of tricuspid annular displacement in normotensive patients with acute symptomatic pulmonary embolism (2014) (58)
- Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease. (2007) (56)
- Methods of Prospective Investigation of Pulmonary Embolism Diagnosis III (PIOPED III). (2008) (55)
- Effect of Selexipag on Morbidity/Mortality in Pulmonary Arterial Hypertension: Results of the GRIPHON Study (2015) (53)
- Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial (2019) (53)
- Predicting the Risk of Venous Thromboembolism in Patients Hospitalized With Heart Failure (2014) (52)
- Monitoring for Pulmonary Hypertension Following Pulmonary Embolism: The INFORM Study. (2016) (51)
- Lung transplantation after long-term mechanical ventilation : results and 1-year follow-up. (2001) (49)
- Clinical and echocardiographic predictors of mortality in acute pulmonary embolism (2016) (48)
- Recurrence of diffuse panbronchiolitis after lung transplantation. (1995) (47)
- Pharmacomechanical thrombolysis of experimental pulmonary emboli. Rapid low-dose intraembolic therapy. (1994) (46)
- Advances in the Diagnosis and Treatment of Acute Pulmonary Embolism (2012) (45)
- Creation of a model comparing 6-minute walk test to metabolic equivalent in evaluating treatment effects in pulmonary arterial hypertension. (2007) (45)
- Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry. (2009) (44)
- Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial (2022) (42)
- Venous and arterial changes in pulmonary veno-occlusive disease, mitral stenosis and fibrosing mediastinitis. (2000) (42)
- Pulmonary embolism--new diagnostic approaches. (1997) (42)
- Venous Thromboembolism Risk and Prophylaxis in the Acute Care Hospital Setting (ENDORSE Survey): Findings in Surgical Patients (2010) (41)
- Clinical Utility and Prognostic Value of Right Atrial Function in Pulmonary Hypertension (2018) (41)
- Massive Pulmonary Embolism: Extracorporeal Membrane Oxygenation and Surgical Pulmonary Embolectomy (2017) (40)
- Glutathione depletion in epithelial lining fluid of lung allograft patients. (1996) (38)
- Iron accumulation in lung allografts after transplantation. (1997) (36)
- Identification, Diagnosis and Treatment of Heparin-induced Thrombocytopenia and Thrombosis: A Registry of Prolonged Heparin Use and Thrombocytopenia among Hospitalized Patients with and without Cardiovascular Disease (2005) (35)
- High utilization rate of vena cava filters in deep vein thrombosis (2005) (35)
- D-dimers and efficacy of clinical risk estimation algorithms: sensitivity in evaluation of acute pulmonary embolism. (2009) (34)
- Mycoplasma hominis pneumonia complicating bilateral lung transplantation: case report and review of the literature. (1997) (34)
- Management appropriateness and outcomes of patients with acute pulmonary embolism (2018) (33)
- Progesterone in Addition to Standard of Care vs Standard of Care Alone in the Treatment of Men Hospitalized With Moderate to Severe COVID-19 (2021) (33)
- Sex differences in the characteristics and short-term prognosis of patients presenting with acute symptomatic pulmonary embolism (2017) (33)
- Clinical probability and D-dimer testing: how should we use them in clinical practice? (2008) (32)
- Rapid Transition from Inhaled Iloprost to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension (2013) (32)
- Selexipag treatment for pulmonary arterial hypertension associated with congenital heart disease after defect correction: insights from the randomised controlled GRIPHON study (2019) (31)
- Pharmacokinetics of Oral Treprostinil Sustained Release Tablets During Chronic Administration to Patients with Pulmonary Arterial Hypertension (2013) (31)
- Venous and arterial changes in pulmonary veno-occlusive disease, mitral stenosis and fibrosing mediastinitis (2000) (31)
- Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial Hypertension (2019) (31)
- Development and External Validation of a Machine Learning Tool to Rule Out COVID-19 Among Adults in the Emergency Department Using Routine Blood Tests: A Large, Multicenter, Real-World Study (2020) (31)
- Efficacy and safety outcomes of recanalisation procedures in patients with acute symptomatic pulmonary embolism: systematic review and network meta-analysis (2017) (31)
- Cystic fibrosis: usefulness of thoracic CT in the examination of patients before lung transplantation. (1999) (30)
- Factors in the technical quality of gadolinium enhanced magnetic resonance angiography for pulmonary embolism in PIOPED III (2012) (29)
- Rapid visualization of massive pulmonary emboli utilizing intravascular ultrasound. (1994) (29)
- Controversies in Diagnosis of Pulmonary Embolism (2011) (29)
- Faculty Opinions recommendation of FDA approves Pradaxa to prevent stroke in people with atrial fibrillation. (2012) (28)
- Diagnosis and Treatment of Pulmonary Embolism During the COVID-19 Pandemic: A Position Paper From the National PERT Consortium. (2020) (28)
- Signal quality of single dose gadobenate dimeglumine pulmonary MRA examinations exceeds quality of MRA performed with double dose gadopentetate dimeglumine (2012) (28)
- Thrombolytic therapy for venous thromboembolism. Utilization by practicing pulmonologists. (1994) (28)
- Chronic thromboembolic pulmonary hypertension. (2006) (27)
- Multidetector computed tomographic pulmonary angiography in patients with a high clinical probability of pulmonary embolism (2016) (27)
- Recommendations for the use of oral treprostinil in clinical practice: a Delphi consensus project pulmonary circulation (2017) (27)
- Complete results of the first randomized, placebo-controlled study of bosentan, a dual endothelin receptor antagonist, in pulmonary arterial hypertension (2002) (27)
- Venous thromboembolism in intensive care patients. (2003) (27)
- Improving Practices in US Hospitals to Prevent Venous Thromboembolism: lessons from ENDORSE. (2010) (27)
- Pilot study evaluating the safety of a combined central venous catheter and inferior vena cava filter in critically ill patients at high risk of pulmonary embolism. (2013) (26)
- Venous Thromboembolism Risk in Ischemic Stroke Patients Receiving Extended-Duration Enoxaparin Prophylaxis: Results From the EXCLAIM Study (2013) (26)
- Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized study. (2014) (26)
- One-year experience with intravenous treprostinil for pulmonary arterial hypertension. (2013) (25)
- The diagnosis and treatment challenges in nosocomial pneumonia. (1999) (25)
- Radiologic issues in lung transplantation for end-stage pulmonary disease. (1997) (25)
- Risk assessment in pulmonary arterial hypertension (PAH): Insights from the GRIPHON study (2018) (25)
- Gender differences in the administration of prophylaxis to prevent deep venous thrombosis (2005) (24)
- Survival benefits of heart and lung transplantation. (1996) (24)
- Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE study. (2021) (24)
- Rivaroxaban Compared with Enoxaparin for the Prevention of Venous Thromboembolism In Acutely Ill Medical Patients: MAGELLAN Study Methodology (2010) (24)
- COVID-19 and Its Implications for Thrombosis and Anticoagulation (2021) (23)
- Management of venous thromboembolic disease. The impact of low-molecular-weight heparin. (1995) (23)
- Appropriate Use Criteria for Ventilation-Perfusion Imaging in Pulmonary Embolism: Summary and Excerpts. (2017) (23)
- Clinical Features and Outcomes of Patients with Sarcoidosis-associated Pulmonary Hypertension (2019) (23)
- A case of disseminated infection with Nocardia brasiliensis in a lung transplant recipient. (1997) (22)
- Does hyperexpansion of the native lung adversely affect outcome after single lung transplantation for emphysema? Preliminary findings. (1998) (21)
- Complications of lung transplantation: radiologic findings. (1996) (21)
- Delayed right heart failure following lung transplantation. (1996) (21)
- Clot Extraction With the FlowTriever Device in Acute Massive Pulmonary Embolism (2016) (21)
- A five-year, single-centre experience on ultrasound-assisted, catheter-directed thrombolysis in patients with pulmonary embolism at high risk and intermediate to high risk. (2018) (21)
- Diagnosis of pulmonary embolism in the coronary care unit. (2009) (20)
- Pulmonary rehabilitation in the surgical patient. Lung transplantation and lung volume reduction surgery. (1998) (19)
- Evaluation of a Device Combining an Inferior Vena Cava Filter and a Central Venous Catheter for Preventing Pulmonary Embolism Among Critically Ill Trauma Patients. (2017) (19)
- Telescoping bronchial anastomoses for unilateral or bilateral sequential lung transplantation: CT appearance. (1997) (19)
- Thrombolytic Therapy for Acute Pulmonary Embolism (2013) (19)
- Results of an Expert Consensus Survey on the Treatment of Pulmonary Arterial Hypertension with Oral Prostacyclin Pathway Agents. (2019) (19)
- Advances in the diagnosis of acute pulmonary embolism (2020) (19)
- Delivery of intravenous treprostinil at low infusion rates using a miniaturized infusion pump in patients with pulmonary arterial hypertension (2006) (19)
- Abnormalities in Hyperpolarized 129Xe Magnetic Resonance Imaging and Spectroscopy in two Patients with Pulmonary Vascular Disease (2016) (19)
- Prognostic value of serum carcinoembryonic antigen levels in patients who undergo lung transplantation. (2001) (19)
- Imatinib in pulmonary arterial hypertension, a randomized, efficacy study (IMPRES) (2011) (18)
- Lung transplantation for Williams-Campbell syndrome. (1998) (18)
- Initial Data Report from LARIAT: A Phase 2 Study of Bardoxolone Methyl in PAH Patients on Stable Background Therapy (2015) (18)
- Prevention of venous thromboembolism in medical patients and outpatients (2009) (18)
- Multicenter Trial of Rivaroxaban for Early Discharge of Pulmonary Embolism From the Emergency Department (MERCURY PE): Rationale and Design. (2016) (17)
- Severe erythroderma as a complication of continuous epoprostenol therapy. (2002) (17)
- Safety and Efficacy of IV Treprostinil for Pulmonary Arterial Hypertension * (2006) (17)
- Controversies in the Management of Life-Threatening Pulmonary Embolism (2015) (17)
- Diagnosis and Treatment of Pulmonary Embolism During the Coronavirus Disease 2019 Pandemic (2020) (17)
- Comparison of 4 Acute Pulmonary Embolism Mortality Risk Scores in Patients Evaluated by Pulmonary Embolism Response Teams (2020) (17)
- Effect of Bosentan and Sildenafil Combination Therapy on Morbidity and Mortality in Pulmonary Arterial Hypertension (PAH): Results From the COMPASS-2 Study (2014) (16)
- Acute pulmonary embolism: comment on "time trends in pulmonary embolism in the United States". (2011) (16)
- Association of NT-proBNP and Long-Term Outcome in Patients with Pulmonary Arterial Hypertension: Insights from the Phase III GRIPHON Study (2019) (16)
- Use of outcome measures in pulmonary hypertension clinical trials. (2015) (16)
- Erratum: Beraprost therapy for pulmonary arterial hypertension (Journal of the American College of Cardiology (2003) 41 (2119-2125)) (2003) (16)
- Road ahead to respiratory health: Experts chart future research directions (2009) (15)
- Cutaneous findings in patients with pulmonary arterial hypertension receiving long-term epoprostenol therapy. (2004) (15)
- Relationship Between Time From Diagnosis and Morbidity or Mortality in Pulmonary Arterial Hypertension: Results From the Phase III GRIPHON Study. (2021) (14)
- Results from the United States CTEPH Registry (US-CTEPH-R): Enrollment Characteristics and 1-Year Follow-up. (2021) (14)
- Rapid and accurate diagnosis of pulmonary emboli in a canine model using intravascular ultrasound imaging. (1991) (14)
- A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ILOPROST INHALATION AS ADD-ON THERAPY TO BOSENTAN IN PULMONARY ARTERIAL HYPERTENSION (PAH) (2005) (13)
- Diagnosing and managing acute pulmonary embolism: role of cardiac troponins. (2003) (13)
- Prophylaxis strategies for patients with acute venous thromboembolism. (2001) (13)
- Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE Trial (2021) (13)
- The impact of comorbidities on selexipag treatment effect in patients with pulmonary arterial hypertension: insights from the GRIPHON study (2021) (13)
- Temporary treatment interruptions with oral selexipag in pulmonary arterial hypertension: Insights from the Prostacyclin (PGI2) Receptor Agonist in Pulmonary Arterial Hypertension (GRIPHON) study. (2017) (13)
- Impact of age on the efficacy and safety of extended-duration thromboprophylaxis in medical patients (2013) (13)
- Clinical and Echocardiographic Predictors of Outcomes in Patients With Pulmonary Hypertension. (2018) (13)
- Incidence and Prevalence of Chronic Thromboembolic Pulmonary Hypertension (2012) (12)
- Home at last? Early discharge for acute pulmonary embolism (2007) (12)
- TRIUMPH 1: Long-Term Safety and Efficacy of Inhaled Treprostinil Sodium in Patients with Pulmonary Arterial Hypertension (PAH) – Two Year Follow-Up. (2009) (12)
- Brain natriuretic peptide: diagnostic and therapeutic implications in pulmonary arterial hypertension. (2005) (12)
- Safety and Tolerability of High-dose Inhaled Treprostinil in Pulmonary Hypertension (2016) (12)
- Results of the FREEDOM–C Study: A Pivotal Study of Oral Treprostinil Used Adjunctively with an ERA and/or PDE5-Inhibitor for the Treatment of PAH. (2009) (12)
- Crew Resource Management and VTE Prophylaxis in Surgery (2011) (11)
- Sustained Plasma Concentrations of Treprostinil Following Chronic Dosing in Patients with Pulmonary Arterial Hypertension (PAH). (2009) (11)
- Systemic Thrombolysis for Pulmonary Embolism: Who and How. (2017) (11)
- Incidence of thrombocytopenia among patients receiving heparin venous thromboembolism prophylaxis. (2012) (11)
- Venous thromboembolism: identifying patients at risk and establishing prophylaxis (2015) (11)
- Treatment with Oral Treprostinil Delays Time to Clinical Worsening in Patients with Pulmonary Arterial Hypertension - Results from FREEDOM-EV (2019) (11)
- Lung transplantation and atrial septostomy in pulmonary arterial hypertension. (2013) (10)
- Heart rate and mortality in patients with acute symptomatic pulmonary embolism. (2021) (10)
- Sitaxsentan Improves 6MW in Patients with Pulmonary Arterial Hypertension (PAH) Related to Connective-Tissue Diseases (CTD) (2004) (10)
- Guidelines and Consensus: Statement on Pregnancy in Pulmonary Hypertension from the Pulmonary Vascular Research Institute (2016) (10)
- What Will It Take to Initiate a Move Toward a More Aggressive Therapeutic Approach to Venous Thromboembolism (2008) (9)
- How I Do It: The PERT Concept: A Step-by-Step Approach to Managing PE. (2020) (9)
- Treatment of pulmonary embolism: anticoagulation, thrombolytic therapy, and complications of therapy. (2011) (9)
- Aggressive Treatment of Intermediate-Risk Patients with Acute Symptomatic Pulmonary Embolism. (2018) (9)
- Faculty Opinions recommendation of American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy. (2020) (9)
- One-Year Echocardiographic, Functional, and Quality of Life Outcomes After Ultrasound-Facilitated Catheter-Based Fibrinolysis for Pulmonary Embolism (2020) (9)
- Catheter-Based Approaches for the Treatment of Acute Pulmonary Embolism (2017) (9)
- Thrombocytopenia Associated with Chronic Intravenous Epoprostenol Therapy (2004) (9)
- Impact of Surgery Type and Co-Morbidities on Venous Thromboembolism prophylaxis Practices in Patients Undergoing Major Surgical Procedures in Acute Care Hospitals Worldwide: A Subanalysis of Data from the ENDORSE Survey (2008) (8)
- Platypnea-Orthodeoxia: Bilateral Lower-Lobe Pulmonary Emboli and Review of Associated Pathophysiology and Management (2011) (8)
- Atrial septostomy: why we still need it. (2007) (8)
- Imatinib Safety And Efficacy: Interim Analysis Of IMPRES Extension Study In Patients With Pulmonary Arterial Hypertension (2012) (8)
- Infection in organ-transplant recipients. (1998) (8)
- Right ventricular responses to massive and submassive pulmonary embolism. (2012) (8)
- Opinions and research priorities. (2005) (7)
- Imatinib Improves Exercise Capacity and Hemodynamics at 24 Weeks as Add-on Therapy in Symptomatic Pulmonary Arterial Hypertension Patients: The IMPRES Study (2011) (7)
- Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension: Results from GRIPHON and its Open-Label Extension (2021) (7)
- The International Medical Prevention Registry on Venous Thromboembolism (IMPROVE): Venous Thromboembolism Prophylaxis Practices in Acutely Ill Medical Patients. (2004) (7)
- Prophylaxis for venous thromboembolism: guidelines translated for the clinician (2010) (7)
- Intermediate-High Risk Pulmonary Embolism (2019) (7)
- [Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): results obtained in France]. (2011) (6)
- The response to inhaled nitric oxide in patients with pulmonary artery hypertension is not masked by baseline vasodilator use. (2005) (6)
- Interventional therapies for venous thromboembolism: vena caval interruption, surgical embolectomy, and catheter-directed interventions. (2010) (6)
- Pulmonary embolism response teams in the challenging era of venous thromboembolism associated with COVID-19 (2020) (6)
- Interhospital Transfer of Patients with Acute Pulmonary Embolism (PE): Challenges and Opportunities. (2021) (6)
- Medical Progress Acute Pulmonary Embolism (2008) (6)
- Pulmonary embolism: the diagnostic repertoire. (1997) (6)
- Development of a research agenda for endovascular treatment of venous thromboembolism: proceedings from a multidisciplinary consensus panel. (2005) (6)
- FREEDOM-C2: Efficacy And Safety Of Oral Treprostinil Diethanolamine In Combination With An ERA And/Or A PDE5 Inhibitor In Patients With Pulmonary Arterial Hypertension (2012) (6)
- New imaging techniques for the diagnosis of pulmonary embolism (1997) (5)
- Thrombolytic therapy in acute pulmonary embolism (2012) (5)
- Vena caval filters in pulmonary embolism. (2001) (5)
- The PERT Concept (2020) (5)
- Faculty Opinions recommendation of 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). (2020) (5)
- Endothelin Receptor Antagonists for the Treatment of Pulmonary Arterial Hypertension (2011) (5)
- 195 Safely Transitioning from Inhaled Iloprost to Inhaled Treprostinil Sodium – Results from a Multicenter Open-Label Study in Patients with Pulmonary Arterial Hypertension (2011) (5)
- Use of the Bedside-Placed Angel Catheter IVC Filter for Venous Thromboembolic Disease in Critically Ill Medical Patients (2020) (5)
- Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial (2022) (5)
- Performance Analysis of the National Early Warning Score and Modified Early Warning Score in the Adaptive COVID-19 Treatment Trial Cohort (2021) (5)
- Risk of venous thromboembolism with use of antipsychotic drugs (2000) (5)
- Diagnosis, prognosis and therapeutic management of acute pulmonary embolism (2016) (4)
- Treatment of acute pulmonary embolism (2011) (4)
- Efficacy and safety of selexipag in pulmonary arterial hypertension (PAH) patients with and without significant cardiovascular (CV) comorbidities (2019) (4)
- The MAGELLAN Study: An Analysis of Outcomes Utilizing D-Dimer (2011) (4)
- Chronic Thromboembolic Pulmonary Hypertension: the Bedside (2021) (4)
- Risk Scores and Risk-Based Stratification of Clinical Worsening Events in Pulmonary Arterial Hypertension Participants Treated with Oral Treprostinil: FREEDOM-EV (2019) (4)
- Pulmonary Embolism in the Intensive Care Unit (1994) (4)
- Classification of Pulmonary Hypertension (2008) (4)
- Overview of Management of Intermediate- and High-Risk Pulmonary Embolism. (2020) (4)
- Consistent Venous Thromboembolism Risk Reduction by Extended- Versus Standard-Duration Enoxaparin Prophylaxis in Subgroups of Acutely Ill Medical Patients in the EXCLAIM Study. (2007) (4)
- Impact and role of pulmonary embolism response teams in venous thromboembolism associated with COVID-19 (2021) (4)
- Acute venous thromboembolism: diagnostic guidelines. (2000) (4)
- Results From the United States Chronic Thromboembolic Pulmonary Hypertension Registry (2021) (4)
- Percutaneous Thrombectomy in Emergency Department Patients with Pulmonary Embolism: The FLARE ED Sub-study. (2020) (4)
- Treatment of Pulmonary Arterial Hypertension (PAH): Data from the Quality Enhancement Research Initiative. (2009) (3)
- Treatment of acute deep venous thrombosis and pulmonary embolism: use of low molecular weight heparin. (2000) (3)
- Pulmonary Arterial Hypertension (2005) (3)
- Individualized Dosing of Selexipag Based on Tolerability in the GRIPHON Study Shows Consistent Efficacy and Safety in Patients With Pulmonary Arterial Hypertension (PAH) (2015) (3)
- Assessing radiation-induced lung injury: Whole versus partial organ endpoints (1993) (3)
- TRIUMPH: LONG-TERM EFFICACY AND SAFETY OF INHALED TREPROSTINIL SODIUM IN PULMONARY ARTERIAL HYPERTENSION (PAH) (2008) (3)
- Contemporary Trends in the Diagnosis and Management of PAH: An Initiative To Close the Care Gap (2010) (3)
- The evolution and impact of the American College of Chest Physicians consensus statement on antithrombotic therapy. (2003) (3)
- Massive Pulmonary Embolism During Pregnancy Successfully Treated With Recombinant Tissue Plasminogen Activator (2017) (3)
- Transitioning Patients From Inhaled Iloprost To Inhaled Treprostinil Sodium: An Interim Analysis (2010) (3)
- Multidisciplinary pulmonary embolism response team in China: A nationwide survey (2021) (3)
- Methodological Issues and Controversies in COVID-19 Coagulopathy: A Tale of Two Storms (2020) (3)
- The Effects of the Degree of Mobility Reduction and Prespecified Risk Factors on Venous Thromboembolism Rates in Acutely Ill Medical Patients in the EXCLAIM Study. (2007) (3)
- Portable Ventilation/Perfusion Scanning is Useful for Evaluating Clinically Significant Pulmonary Embolism in the ICU Despite Abnormal Chest Radiography (2018) (3)
- Chronic Thromboembolic Pulmonary Hypertension: the Bench (2021) (3)
- An Eight-year, Single-center Experience on Ultrasound Assisted Thrombolysis with Moderate-dose, Slow-infusion Regimen in Pulmonary Embolism. (2022) (2)
- ONE YEAR EXPERIENCE WITH INTRAVENOUS TREPROSTINIL IN PULMONARY ARTERIAL HYPERTENSION (PAH) PATIENTS (2005) (2)
- Treatment effect of selexipag on time to disease progression when initiated early in pulmonary arterial hypertension (PAH) patients: GRIPHON and TRITON pooled analysis (2021) (2)
- Treatment-related biomarkers in pulmonary hypertension patients on oral therapies (2020) (2)
- AbstractEvaluation of a Device Combining an Inferior Vena Cava Filter and a Central Venous Catheter for Preventing Pulmonary Embolism Among Critically Ill Trauma Patients (2017) (2)
- Preliminary Data from the United States CTEPH Registry (2017) (2)
- Efficacy And Safety Outcomes of Recanalization Procedures In Patients with Acute Symptomatic Pulmonary Embolism: Systematic Review And Network Meta-Analysis (2017) (2)
- DISSEMINATED INFECTION WITH NOCARDIA BRASILIENSIS IN A LUNG TRANSPLANT RECIPIENT (1997) (2)
- Anticoagulant Therapy Is Not Associated with Long Term Outcome in Patients with Pulmonary Arterial Hypertension (PAH): Insights from the GRIPHON Study (2016) (2)
- Effect of selexipag on long-term outcomes in key subgroups of patients with pulmonary arterial hypertension (PAH): GRIPHON study results (2015) (2)
- Thrombolytic therapy for venous thromboembolism: current clinical practice. (2009) (2)
- Pulmonary infarction: A disease of the (mostly) young (2018) (2)
- 3:00 PM Abstract No. 221 Optimum duration and dose of r-tPA with the acoustic pulse thrombolysisis procedure for ntermediate-risk (submassive) pulmonary embolism: OPTALYSE PE (2018) (2)
- Early selexipag initiation and long-term outcomes: Insights from RCTs in PAH (2022) (2)
- DIAGNOSTIC WORK UP OF PAH: DATA FROM THE QUALITY ENHANCEMENT RESEARCH INITIATIVE (2007) (2)
- United States CTEPH Registry: Differences Between Operated and Non-Operated Subjects in Baseline Data and 1-Year Outcomes (2020) (2)
- Inhaled Treprostinil Dose in Pulmonary Hypertension Associated with Interstitial Lung Disease and Its Effects on Clinical Outcomes. (2022) (2)
- 1001-13 Gender bias against women: Men receive prophylaxis more often to prevent deep venous thrombosis (2004) (2)
- Three dimensional spect lung perfusion scans in designing radiation beams and in predicting and assessing the physiologic consequences of thoracic irradiation (1992) (2)
- Direct oral anticoagulants in chronic thromboembolic pulmonary hypertension (2021) (2)
- Management of selexipag interruptions in the GRIPHON study (2016) (2)
- ICU stay after single lung transplantation. (1996) (2)
- THE IMPACT OF INHALED TREPROSTINIL ON PATIENT LUNG FUNCTION: RESULTS FROM THE INCREASE STUDY (2020) (2)
- PULMONARY HYALINIZING GRANULOMA PRESENTING WITH HEMOPTYSIS AND HILAR MASS (2007) (2)
- The United States Chronic Thromboembolic Pulmonary Hypertension Registry: Protocol for a Prospective, Longitudinal Study (2021) (2)
- Study Design of the Phase 3 ADVANCE Program Evaluating Time-to-Clinical Events and Exercise Capacity in Patients with Pulmonary Arterial Hypertension Treated with Ralinepag (2019) (2)
- Pulmonary hypertension secondary to pulmonary veno-occlusive disease complicated by right heart failure, hypotension and acute kidney injury (2016) (1)
- The Impact of Age on the Efficacy and Safety of Extended-Duration Thromboprophylaxis in Acutely Ill Medical Patients with Recent Immobility: A Sub-Group Analysis from the EXCLAIM Study (2008) (1)
- The Diagnostic and Therapeutic Approach to Acute Venous Thromboembolism (1998) (1)
- Pulmonary Hypertension Roundtable: Recapping 5 Years, Exploring Emerging Approaches (2006) (1)
- Few predictors of massive deep vein thrombosis (2005) (1)
- Ralinepag Plasma Levels Correlate with Improvements in Functional and Hemodynamic Parameters in Patients with Pulmonary Arterial Hypertension (2019) (1)
- The Pulmonary Circulation (2015) (1)
- Dose-response relationship of oral treprostinil for secondary endpoints in the FREEDOM-EV study (2019) (1)
- Faculty Opinions recommendation of Obesity, sedentary lifestyle, and video games: The new thrombophilia cocktail in adolescents. (2020) (1)
- Venous Thromboembolism Prophylaxis Practices in Acutely Ill Medical Patients with Heart Failure (NYHA Class III or IV): Findings from IMPROVE. (2005) (1)
- Venous Thromboembolism Risk and Prophylaxis Practices in Surgical Patients with Active Cancer: Findings from the Global ENDORSE Survey. (2008) (1)
- Surgically Curable Pulmonary Hypertension: A View From the Experts (2003) (1)
- Epoprostenol-Induced Leukocytoclastic Vasculitis (2004) (1)
- 3016Long-term survival and safety with selexipag in patients with pulmonary arterial hypertension: results from the GRIPHON study and its open-label extension (2018) (1)
- ADDING DECISION SUPPORT TO COMPUTERIZED PROVIDER ORDER ENTRY IMPROVES VENOUS THROMBOEMBOLISM PROPHYLAXIS RATES (2009) (1)
- Extended-Duration Enoxaparin for Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients: An Evaluation of the EXCLAIM Study Based on a Recently Recommended Composite Efficacy Endpoint. (2007) (1)
- Radiologic mimics of pulmonary embolism (2021) (1)
- Development and External Validation of a Machine Learning Tool to Rule Out COVID-19 Among Adults in the Emergency Department Using Routine Blood Tests: A Large, Multicenter, Real-World Study (Preprint) (2020) (1)
- Progesterone in Addition to Standard of Care Versus Standard of Care Alone in the Treatment of Men Admitted to the Hospital with Moderate to Severe COVID-19: A Randomised Control Phase 1 Trial (2020) (1)
- Ask the Expert: Management of Right Ventricular Failure in Acute Pulmonary Embolism (2015) (1)
- OBESITY, HYPERTENSION, AND SLEEP APNEA CONFOUND THE DIAGNOSIS OF PULMONARY ARTERIAL HYPERTENSION (2005) (1)
- COMPARISON OF EFFECTS OF INHALED TREPROSTINIL ON LUNG FUNCTION IN PATIENTS WITH PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE AND PULMONARY ARTERIAL HYPERTENSION (2021) (1)
- Reply: Efficacy and Safety of Low-Dose Systemic Fibrinolytic Therapy for Acute Submassive Pulmonary Embolism. (2021) (1)
- DOSE RESPONSE ANALYSIS OF INHALED TREPROSTINIL IN PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE AND ITS EFFECTS ON CLINICAL WORSENING (2021) (1)
- The Diagnosis of Acute Pulmonary Embolism (2009) (1)
- SELEXIPAG FOR PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONGENITAL HEART DISEASE (PAH-CHD) AFTER DEFECT CORRECTION: INSIGHTS FROM THE RANDOMISED CONTROLLED GRIPHON STUDY (2016) (1)
- Combination Therapy for PAH: Current Rationale, Future Concepts (2006) (1)
- Lung transplantation at Duke University Medical Center. (1998) (1)
- 858-1 Risk factors for and inadequate prophylaxis against upper extremity deep vein thrombosis (2004) (1)
- Venous thromboembolism prophylaxis practices in acutely ill medical patients with either previous cancer or currently active cancer: Findings from IMPROVE (2004) (1)
- Relationship Between Time From Diagnosis and Morbidity/Mortality in Pulmonary Arterial Hypertension (2021) (1)
- United States Chronic Thromboembolic Pulmonary Hypertension Registry: Protocol Design. (2021) (1)
- Venous Thromboembolism Prophylaxis With Sequential Compression Devices in Critically Ill Medical Patients: Analysis of the Project IMPACT Databas (2003) (1)
- 1123-180 Incidence and evaluation of heparin-induced thrombocytopenia (HIT) among patients treated with prolonged heparin and among thrombocytopenic patients in the cardiac care unit: Preliminary results of the CATCH registry (2004) (1)
- 100 Questions & Answers About Deep Vein Thrombosis and Pulmonary Embolism (2007) (1)
- Faculty Opinions recommendation of Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study. (2020) (1)
- Treatment and Palliation of Symptoms in Patients With Advanced Pulmonary Arterial Hypertension (2018) (1)
- Using risk stratification to determine which therapeutic intervention is right for your acute pulmonary embolism patient (0)
- Faculty Opinions recommendation of Recognition of unprovoked (idiopathic) pulmonary embolism-Prospective observational study. (2020) (0)
- Pulmonary arterial hypertension-related morbidity is prognostic for survival: Insights from the SERAPHIN and GRIPHON studies (2017) (0)
- EmbolismTherapy for Acute Pulmonary (2009) (0)
- 1123-185 Is there regional variation in levels of serum brain natriuretic peptide in patients with pulmonary hypertension? (2004) (0)
- Retrospective observational study of pulmonary hypertension patients dosed with greater than 9 breaths qid of inhaled treprostinil (2013) (0)
- Pharyngeal Antisepsis to Reduce COVID-19 Pneumonia (2020) (0)
- Comparison of Lung Transplant Recipients Who Developed Respiratory Viral Infection to Those Who Avoided Respiratory Viral Infection * Patients With Patients Without Respiratory Viral Respiratory (0)
- Faculty Opinions recommendation of Guidelines for the use of retrievable and convertible vena cava filters: report from the Society of Interventional Radiology multidisciplinary consensus conference. (2012) (0)
- The United States Chronic Thromboembolic Pulmonary Hypertension Registry: Protocol for a Prospective, Longitudinal Study (Preprint) (2020) (0)
- Deep Venous Thrombosis: A Comparison of Ethnic Groups From the DVT FREE Registr (2003) (0)
- Inhaled Treprostinil in Group 3 Pulmonary Hypertension. Reply. (2021) (0)
- Long-term inhaled treprostinil for PH-ILD: INCREASE open-label extension study. (2023) (0)
- New Oral Anticoagulants: Benefit-Risk Profile, Recurrence Rates, and Long-term Complications in Patients Treated for Established VTE (2012) (0)
- Common Risk Factors for Deep Venous Thrombosis Risk Factor Hypercoagulable State Age > 40 years Antithrombin III deficiency Recent surgery Protein C or S deficiency Malignancy Factor V Leiden mutation Pregnancy or Antiphospholipid antibody syndrome postpartum Immobilization or Dysfibrinogenemia para (0)
- Clinical Features and Outcomes of Patients with Sarcoidosis-associated Pulmonary Hypertension (2019) (0)
- Faculty Opinions recommendation of A prospective long-term study of 220 patients with a retrievable vena cava filter for secondary prevention of venous thromboembolism. (2012) (0)
- Faculty Opinions recommendation of Risk factors for venous thromboembolism. (2012) (0)
- Faculty Opinions recommendation of Clinical practice. Acute pulmonary embolism. (2012) (0)
- Faculty Opinions recommendation of Diagnosis of pulmonary embolism during pregnancy: A multicenter prospective management outcome study. (2020) (0)
- TREATMENT BENEFITS ASSOCIATED WITH OPEN LABEL ORAL TREPROSTINIL AFTER CLINICAL WORSENING IN THE PHASE 3 FREEDOM-EV STUDY FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (2019) (0)
- Pulmoner hipertansiyonda tedavi hedefleri Treatment goals of pulmonary hypertension (2014) (0)
- Does Obesity Influence Physician Practices in Provision of Prophylaxis for Venous Thromboembolism? Lessons from IMPROVE (2004) (0)
- Faculty Opinions recommendation of Dabigatran versus warfarin in the treatment of acute venous thromboembolism. (2012) (0)
- Thrombocytopenia Is More Common and Nadir Occurs Earlier with Unfractionated Heparin Than with Low Molecular Weight Heparin - Results from the Prospective Catch Registry. (2004) (0)
- Venous Thromboembolism Risk in Stroke Patients Receiving Extended-Duration Enoxaparin Prophylaxis: Sub-Analysis of the EXCLAIM Study (2008) (0)
- Immune-mediated diseases and thromboembolic events: a modified Delphi panel (2021) (0)
- Faculty Opinions recommendation of Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) (2012) (0)
- Reply: Aspiration Thrombectomy in Intermediate-High Risk Pulmonary Embolism Patients: More Work Ahead. (2021) (0)
- Factors at Admission That Are Predictive of Increased In-Hospital Bleeding in Acutely Ill Medical Patients: Findings from the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE). (2005) (0)
- Faculty Opinions recommendation of Effect of the Pulmonary Embolism Rule-Out Criteria on Subsequent Thromboembolic Events Among Low-Risk Emergency Department Patients: The PROPER Randomized Clinical Trial. (2020) (0)
- Determining the Optimal Approach to Initiating Oral, Inhaled, and Intravenous Therapies in Clinical Practice: Maximal Upfront Therapy Is Best (2016) (0)
- Immobility and advanced age: Critical factors contributing to the overall risk of venous thromboembolism in medical patients. (2003) (0)
- Faculty Opinions recommendation of Hemodynamic effects of fluid loading in acute massive pulmonary embolism. (2012) (0)
- Sarcoidosis [2] (multiple letters) (1997) (0)
- Protect your health in the air. Most people with chronic health conditions can travel by air safely--if they take a few precautions. (2002) (0)
- Chapter 61 – Pulmonary Embolism (2010) (0)
- Antithrombotic therapy for venous thromboembolic disease. (2001) (0)
- P1613Efficacy and safety outcomes of recanalization procedures in patients with acute symptomatic pulmonary embolism: systematic review and network meta-analysis (2017) (0)
- Reassessing Patients Over Time : How To Follow Patients on Treatment (2009) (0)
- RapidLow-DoseIntraembolic Therapy (2015) (0)
- REVEAL LITE 2 RISK ASSESSMENT IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION FROM THE GRIPHON STUDY: A POST-HOC ANALYSIS DEMONSTRATES ASSOCIATION OF RISK STATUS WITH LONG-TERM OUTCOMES (2021) (0)
- Advance Outcomes - A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in Subjects with Pulmonary Arterial Hypertension (2020) (0)
- Acute renal insufficiency or likely causes or findings with acute renal insufficiency ● Severely dehydrated ● Severe hemorrhage (2009) (0)
- Inside the Surgical Suite: Meeting the Challenges of CTEPH (2003) (0)
- 858-3 Subcutaneous treprostinil therapy evokes both survival benefit and continuous dose-dependent efficacy improvements in patients with pulmonary arterial hypertension: A long-term European multicentre analysis of 112 patients (2016) (0)
- Pulmonary Embolism. (2022) (0)
- Using a knowledge translation program to facilitate guideline‐ and evidence‐based patient management: the PAH‐QuERI Extension Program (2022) (0)
- Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism (2019) (0)
- Chapter 57 – Pulmonary Embolism (2014) (0)
- PROSTACYCLIN INTERNATIONAL EXPERT PANEL CONSENSUS-BASED RECOMMENDATIONS FOR THE USE OF SELEXIPAG IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (2019) (0)
- Abstract No. 602 Rationale and experimental design of the KNOCOUT PE trial: an international EKoSoNic® registry of the treatment and clinical outcomes of patients with pulmonary embolism (2019) (0)
- Redefining the Window of Opportunity in Lung Transplantation (2004) (0)
- 60 COMPARISON OF METABOLIC EQUIVALENT WITH THE 6-MINUTE WALK TEST AS A MEASURE OF EXERCISE CAPACITY AND OUTCOME PREDICTOR IN PULMONARY ARTERIAL HYPERTENSION: RESULTS FROM THE INTRAVENOUS TREPROSTINIL STUDY. (2006) (0)
- Seeking a Consensus on PH: Challenges Left by the Venice Symposium (2003) (0)
- Faculty Opinions recommendation of The problem of under-diagnosis and over-diagnosis of pulmonary embolism. (2020) (0)
- Changes In Pro-Brain Natriuretic Peptide Level And Its Correlation With Exercise Capacity And Right Ventricular Parameters In Pulmonary Arterial Hypertension Patients Receiving Intravenous Epoprostenol (2011) (0)
- 56 Veletri® and Flolan® (Epoprostenol Sodium) in the Treatment of Pulmonary Arterial Hypertension (2012) (0)
- Prophylaxis for deep venous thrombosis: the ACCP antithrombotic statement, revisited. (1998) (0)
- PAH-Associated Congenital Heart Disease: Finding Common Ground With Primary Pulmonary Hypertension (2003) (0)
- Evaluation of the risk and prophylaxis of venous thrombo-embolic events in medical hospitalised patients: results in France of the international survey endorse (2009) (0)
- Faculty Opinions recommendation of Clinical, laboratory, roentgenographic, and electrocardiographic findings in patients with acute pulmonary embolism and no pre-existing cardiac or pulmonary disease. (2012) (0)
- Pulmonary Hypertension Roundtable: Integrating Current Strategies for Continuing Assessment of Pulmonary Arterial Hypertension (2005) (0)
- A Multinational Comparison of Prophylaxis Practices for Venous Thromboembolism During Medical Intensive Care: Findings from IMPROVE (2004) (0)
- Faculty Opinions recommendation of Catheter embolectomy for acute pulmonary embolism. (2012) (0)
- Dosing of Tissue-Type Plasminogen Activator With the Acoustic Pulse Thrombolysis Procedure for Intermediate-Risk (Submassive) Pulmonary Embolism: ULTIMA, SEATTLE II, OPTALYSE PE (2017) (0)
- Patient Reported Quality Of Life After Rapid Transition From IV Epoprostenol To IV Treprostinil At Multiple Centers (2012) (0)
- Deep venous thrombosis and pulmonary thromboembolism: evolving concepts and controversies. Preface. (2008) (0)
- THE IMPACT OF HEMODYNAMIC PARAMETERS ON INHALED TREPROSTINIL TREATMENT RESPONSE: A SUBGROUP ANALYSIS FROM THE INCREASE TRIAL (2021) (0)
- Managing pulmonary arterial hypertension and optimizing treatment options. Introduction. (2013) (0)
- Deep venous thrombosis: outpatient therapy with low-molecular-weight heparin. (1999) (0)
- PULMONARY THROMBOEMBOLISM | Deep Venous Thrombosis (2006) (0)
- HIV-APAH Compared To IPAH: Baseline Characteristics And 2 Year Outcomes From The REVEAL Registry (2010) (0)
- Table of Contents 3 Pulmonary Embolism : An International Crisis (2019) (0)
- CHARACTERISTICS OF PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH ELEVATED PULMONARY CAPILLARY WEDGE PRESSURE (2005) (0)
- Faculty Opinions recommendation of Introduction to dual-energy computed tomography. (2020) (0)
- Incidence and Risk Factors for In-Hospital Bleeding in Acutely Ill Medical Patients: Findings from IMPROVE. (2004) (0)
- S0880 Examining the Link Between Autoimmune Disease and Thromboembolic Events: A Modified Delphi Panel Approach (2020) (0)
- Faculty Opinions recommendation of Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? (2012) (0)
- Without lungs (1997) (0)
- Physiologic changes in the native lung following single lung transplantation for emphysema (1997) (0)
- Interventional for Venous Thromboembolism: Caval Interruption, Surgical Embolectomy, and Catheter-Directed Interventions (2010) (0)
- The Diagnosis and Management of Acute Pulmonary Embolism in 2021: Evolving Strategies (2021) (0)
- Controversies and Evolving Concepts in Acute Pulmonary Embolism (2017) (0)
- Commentary: Persistent Gaps in VTE Prophylaxis in Orthopedic Surgery (2011) (0)
- Chapter 26 – Pulmonary Embolism (2006) (0)
- Initial and Long‐Term Treatment of Patients with Pulmonary Embolism (2009) (0)
- Faculty Opinions recommendation of A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception. (2020) (0)
- Helical Computed Tomography and Magnetic Resonance Imaging in the Diagnosis of Venous Thromboembolic Disease: Case Report and Review of the Literature (1997) (0)
- Faculty Opinions recommendation of Assessing clinical probability of pulmonary embolism: prospective validation of the simplified Geneva score. (2020) (0)
- Profiles in Pulmonary Hypertension Cardiologist Nazzareno Galiè : A Guiding Light for Worldwide Consensus on Pulmonary Hypertension (2003) (0)
- Red Blood Cell S-Nitrosohemoglobin Deficiency in Pulmonary Arterial Hypertension. (2004) (0)
- TREATMENT OF PAH: DATA FROM THE QUALITY ENHANCEMENT RESEARCH INITIATIVE (2007) (0)
- Bridging the Gap Between Specialists With Insights From an Expert Panel (2002) (0)
- Under the Tent of the New ACCP Guidelines in PAH: Room for Debate, Comment, Analysis (2004) (0)
- Predicting Future Directions in Pulmonary Hypertension (2003) (0)
- 1017: PILOT STUDY EVALUATING THE SAFETY AND EFFECTIVENESS OF THE ANGEL™ CATHETER IN CRITICALLY ILL PATIENTS AT HIGH RISK OF PULMONARY EMBOLISM (2012) (0)
- Tuberculosis in the Nineties (1996) (0)
- PULMONARY THROMBOEMBOLISM | Pulmonary Emboli and Pulmonary Infarcts (2006) (0)
- The Staging System for Non- small Cell Lung Cancer (2015) (0)
- Long term recovery of right ventricular function after treatment of intermediate and high risk pulmonary emboli. (2023) (0)
- The Prostacyclin Story: From Discovery to Future Directions (2002) (0)
- A Study of Venous Thromboembolism Treatment and Prophylaxis in US Hospitals Enrolled in the NABOR (National Anticoagulation Benchmark & Outcomes Report) Program (2004) (0)
- Faculty Opinions recommendation of Assessment of right ventricular function in acute pulmonary embolism. (2020) (0)
- Identification of Medical Patients Who Should Receive Venous Thromboembolism Prophylaxis. (2004) (0)
- Venous thromboembolic risk and suboptimal prophylaxis in the US acute hospital care setting: Findings from the ENDORSE study (2007) (0)
- The Unmet Need for Extended Thromboprophylaxis in Acutely Ill Medical Patients: The Findings of IMPROVE, ENDORSE and EXCLAIM. (2008) (0)
- Abstract 11192: Diagnosis and Management of PAH: An Initiative to Close the Care Gap (2010) (0)
- Brain Natriuretic Peptide Levels Correlate With Hemodynamic and Functional Parameters in Patients With Pulmonary Arterial Hypertension (2004) (0)
- Post-PE Management (2020) (0)
- Recapping Highlights from Pulmonary Hypertension Association Scientific Sessions and Identifying Key Issues Driving Translational Research (2004) (0)
- Faculty Opinions recommendation of Free-floating right heart thrombus with acute massive pulmonary embolism: a case report and review of the literature. (2020) (0)
- 158 Physical and biological predictors of radiation-induced whole lung injury: Early results of a prospective study (1996) (0)
- CORRELATION OF NT-PROBNP WITH OTHER NONINVASIVE PARAMETERS IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (2005) (0)
- Early selexipag initiation and long-term outcomes: insights from randomised controlled trials in pulmonary arterial hypertension (2023) (0)
- Outpatient Management of Acute Deep Venous Thrombosis (2002) (0)
- Presenting Highlights from Two Exceptional Meetings on Pulmonary Hypertension (2003) (0)
- An Open-Label Extension Trial Of UT-15C SR In Subjects With Pulmonary Arterial Hypertension -- Interim Results Of Patients From Freedom - C (2011) (0)
- Sounds like a PE to me. (1997) (0)
- Faculty Opinions recommendation of Isoproterenol in massive pulmonary embolism: haemodynamic and clinical effects. (2012) (0)
- Making History in Miami at PHA's 6th International Conference (2004) (0)
- The diagnosis of acute venous thromboembolism. (2005) (0)
- Protocols in Heart and Lung Transplantation: An Essential Guide to Preoperative Assessment and Timing to Improve Outcomes (2004) (0)
- A New Source of Information for a New Era in Treatment (2002) (0)
- 5998Echocardiographic improvement after short-duration, low-dose tPA regimens for ultrasound-facilitated, catheter-based fibrinolysis in submassive PE: OPTALYSE-PE (2017) (0)
- Inhaled Treprostinil and FVC Change in Patients With Interstitial Lung Disease and Associated Pulmonary Hypertension (2021) (0)
- Inhaled treprostinil in patients with pulmonary hypertension due to interstitial lung disease: event-free survival in INCREASE study open-label extension (2022) (0)
- PCV47 THE NATIONAL ANTICOAGULATION BENCHMARK AND OUTCOMES REPORT (NABORTM): EVIDENCE OF A SIGNIFICANT DIFFERENCE BETWEEN GUIDELINES AND ACTUAL PRACTICE (2004) (0)
- Abstract (2007) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Victor F. Tapson?
Victor F. Tapson is affiliated with the following schools:
